Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Your DNA could predict your heart attack risk – but does knowing help?

NCT ID NCT06542432

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: MyOme Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 37 times

Summary

This study looks at whether giving people a combined genetic and lifestyle risk score for heart disease helps doctors make better decisions. About 1,000 adults with moderate risk will be randomly assigned to receive their score or not. Researchers will track if those who get their score are more likely to start cholesterol medication or have better cholesterol levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that giving patients a personalized genetic risk score helps doctors start cholesterol-lowering drugs earlier, potentially preventing heart attacks.

What could go wrong

This is an observational study, not a treatment trial. It only measures if risk information changes behavior, not whether it actually reduces heart disease. Results may not apply to everyone.

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder Coronary Disease Genetic Risk Score heart disorder myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.